139 related articles for article (PubMed ID: 20134101)
1. Is pentraxin 3 involved in obesity-induced decrease in arterial distensibility?
Miyaki A; Maeda S; Yoshizawa M; Misono M; Sasai H; Shimojo N; Tanaka K; Ajisaka R
J Atheroscler Thromb; 2010 Mar; 17(3):278-84. PubMed ID: 20134101
[TBL] [Abstract][Full Text] [Related]
2. Association of plasma pentraxin 3 with arterial stiffness in overweight and obese individuals.
Miyaki A; Maeda S; Choi Y; Akazawa N; Eto M; Tanaka K; Ajisaka R
Am J Hypertens; 2013 Oct; 26(10):1250-5. PubMed ID: 23771016
[TBL] [Abstract][Full Text] [Related]
3. Plasma pentraxin 3 concentration increases in endurance-trained men.
Miyaki A; Maeda S; Otsuki T; Ajisaka R
Med Sci Sports Exerc; 2011 Jan; 43(1):12-7. PubMed ID: 20508541
[TBL] [Abstract][Full Text] [Related]
4. Habitual aerobic exercise increases plasma pentraxin 3 levels in middle-aged and elderly women.
Miyaki A; Maeda S; Choi Y; Akazawa N; Tanabe Y; Ajisaka R
Appl Physiol Nutr Metab; 2012 Oct; 37(5):907-11. PubMed ID: 22784030
[TBL] [Abstract][Full Text] [Related]
5. Serum pentraxin 3 levels are negatively associated with carotid intima media thickness in non-obese rheumatoid arthritis patients.
Kahlow BS; Petisco R; Skare TL; Goeldner I; Nisihara RM; Messias-Reason IJ
Int J Cardiol; 2016 Oct; 221():298-301. PubMed ID: 27404695
[TBL] [Abstract][Full Text] [Related]
6. Pentraxin 3 increases in adult overweight and obese men after weight loss by dietary modification with exercise training.
Zempo-Miyaki A; Kumagai H; Yoshikawa T; Myoenzono K; So R; Otsuki T; Tanaka K; Maeda S
Appl Physiol Nutr Metab; 2019 Feb; 44(2):111-117. PubMed ID: 29990442
[TBL] [Abstract][Full Text] [Related]
7. The long pentraxin 3 (PTX3): a novel prognostic inflammatory marker for mortality in acute chest pain.
Brügger-Andersen T; Pönitz V; Kontny F; Staines H; Grundt H; Sagara M; Nilsen DW
Thromb Haemost; 2009 Sep; 102(3):555-63. PubMed ID: 19718477
[TBL] [Abstract][Full Text] [Related]
8. Plasma Pentraxin 3, but not high-sensitivity C-reactive protein, is a useful inflammatory biomarker for predicting cognitive impairment in elderly hypertensive patients.
Yano Y; Matsuda S; Hatakeyama K; Sato Y; Imamura T; Shimada K; Kodama T; Kario K; Asada Y
J Gerontol A Biol Sci Med Sci; 2010 May; 65(5):547-52. PubMed ID: 20203097
[TBL] [Abstract][Full Text] [Related]
9. Effect of habitual aerobic exercise on body weight and arterial function in overweight and obese men.
Miyaki A; Maeda S; Yoshizawa M; Misono M; Saito Y; Sasai H; Kim MK; Nakata Y; Tanaka K; Ajisaka R
Am J Cardiol; 2009 Sep; 104(6):823-8. PubMed ID: 19733718
[TBL] [Abstract][Full Text] [Related]
10. Gastric bypass-induced weight loss alters obesity-associated patterns of plasma pentraxin-3 and systemic inflammatory markers.
Barazzoni R; Palmisano S; Gortan Cappellari G; Giuricin M; Moretti E; Vinci P; Semolic A; Guarnieri G; Zanetti M; Manzini Nd
Surg Obes Relat Dis; 2016 Jan; 12(1):23-32. PubMed ID: 26277450
[TBL] [Abstract][Full Text] [Related]
11. The impact of obesity on pentraxin 3 and inflammatory milieu to acute aerobic exercise.
Slusher AL; Mock JT; Whitehurst M; Maharaj A; Huang CJ
Metabolism; 2015 Feb; 64(2):323-9. PubMed ID: 25467846
[TBL] [Abstract][Full Text] [Related]
12. [The role of long pentraxin 3, a new inflammatory mediator in inflammatory responses].
Okutani D
Nihon Rinsho Meneki Gakkai Kaishi; 2006 Jun; 29(3):107-13. PubMed ID: 16819259
[TBL] [Abstract][Full Text] [Related]
13. Production of the long pentraxin PTX3 in advanced atherosclerotic plaques.
Rolph MS; Zimmer S; Bottazzi B; Garlanda C; Mantovani A; Hansson GK
Arterioscler Thromb Vasc Biol; 2002 May; 22(5):e10-4. PubMed ID: 12006411
[TBL] [Abstract][Full Text] [Related]
14. Exercise reduced pentraxin 3 levels produced by endotoxin-stimulated human peripheral blood mononuclear cells in obese individuals.
Slusher AL; Shibata Y; Whitehurst M; Maharaj A; Quiles JM; Huang CJ
Exp Biol Med (Maywood); 2017 Jun; 242(12):1279-1286. PubMed ID: 28440716
[TBL] [Abstract][Full Text] [Related]
15. Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis.
Tombetti E; Di Chio MC; Sartorelli S; Papa M; Salerno A; Bottazzi B; Bozzolo EP; Greco M; Rovere-Querini P; Baldissera E; Del Maschio A; Mantovani A; De Cobelli F; Sabbadini MG; Manfredi AA
Arthritis Res Ther; 2014 Nov; 16(6):479. PubMed ID: 25394473
[TBL] [Abstract][Full Text] [Related]
16. Obesity and high waist circumference are associated with low circulating pentraxin-3 in acute coronary syndrome.
Barazzoni R; Aleksova A; Carriere C; Cattin MR; Zanetti M; Vinci P; Stolfo D; Guarnieri G; Sinagra G
Cardiovasc Diabetol; 2013 Nov; 12():167. PubMed ID: 24215445
[TBL] [Abstract][Full Text] [Related]
17. The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases.
Norata GD; Garlanda C; Catapano AL
Trends Cardiovasc Med; 2010 Feb; 20(2):35-40. PubMed ID: 20656213
[TBL] [Abstract][Full Text] [Related]
18. Plasma PTX3 protein levels inversely correlate with insulin secretion and obesity, whereas visceral adipose tissue PTX3 gene expression is increased in obesity.
Osorio-Conles O; Guitart M; Chacón MR; Maymo-Masip E; Moreno-Navarrete JM; Montori-Grau M; Näf S; Fernandez-Real JM; Vendrell J; Gómez-Foix AM
Am J Physiol Endocrinol Metab; 2011 Dec; 301(6):E1254-61. PubMed ID: 21900125
[TBL] [Abstract][Full Text] [Related]
19. Pentraxin 3 is associated with disease activity but not atherosclerosis in patients with systemic lupus erythematosus.
Shimada Y; Asanuma YF; Yokota K; Yoshida Y; Kajiyama H; Sato K; Akiyama Y; Mimura T
Mod Rheumatol; 2014 Jan; 24(1):78-85. PubMed ID: 24261762
[TBL] [Abstract][Full Text] [Related]
20. Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile.
Zanetti M; Bosutti A; Ferreira C; Vinci P; Biolo G; Fonda M; Valente M; Cattin L; Guarnieri G; Barazzoni R
Clin Exp Med; 2009 Sep; 9(3):243-8. PubMed ID: 19238513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
